Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» semaglutide
semaglutide
Novo Nordisk quietly nabs a rare 'breakthrough' status in NASH for its cash cow
Endpoints
Fri, 10/30/20 - 10:25 am
Novo Nordisk
earnings
NASH
semaglutide
breakthrough therapy
FDA
Novo adds weight to its obesity goals
EP Vantage
Thu, 09/10/20 - 10:17 am
Novo Nordisk
semaglutide
obesity
Novo launches type 2 diabetes pill in UK after NICE waives review
Pharmaforum
Tue, 09/1/20 - 10:44 am
Novo Nordisk
UK
type 2 diabetes
diabetes
Rybelsus
semaglutide
NICE
Novo Nordisk axes experimental obesity drugs after success with later-stage meds
Fierce Biotech
Thu, 08/6/20 - 11:20 pm
Novo Nordisk
obesity
semaglutide
Novo's diabetes drug also appears to work in NASH
BioPharma Dive
Thu, 05/7/20 - 12:08 am
Novo Nordisk
NASH
semaglutide
Mark Your Calendar For These September PDUFA Dates
Yahoo/Benzinga
Wed, 08/28/19 - 12:53 pm
FDA
Roche
Celgene
Tecentriq
Xeris Pharmaceuticals
Gvoke
Ardelyx
tenapanor
Merck
Pifeltro
Delstrigo
Novo Nordisk
semaglutide
JNJ
Genmab
daratumumab
Invokana
ADA: Lilly's Trulicity cuts heart risks by 12%. Is it enough to fend off semaglutide?
Fierce Pharma
Mon, 06/10/19 - 09:27 am
Eli Lilly
ADA
diabetes
heart attack
stroke
Trulicity
Novo Nordisk
semaglutide
Novo Nordisk seeks FDA nod for oral diabetes pill
Drug Delivery Business News
Thu, 03/21/19 - 09:49 am
Novo Nordisk
FDA
semaglutide
diabetes
Novo's Victoza won't face Teva copies until 2023. Can semaglutide fill the gap by then?
Fierce Pharma
Mon, 03/18/19 - 05:05 pm
Novo Nordisk
diabetes
Teva Pharmaceutical
Victoza
semaglutide
Novo bets on swift FDA review for oral diabetes drug semaglutide
Endpoints
Fri, 02/1/19 - 09:50 am
Novo Nordisk
earnings
semaglutide
FDA
The 20 Hottest Pipeline Drugs to Watch in 2019
BioSpace
Sun, 01/6/19 - 02:09 pm
VX-659 + tezacaftor + ivacaftor
semaglutide
JCAR017
ARGX-113
aducanumab
elafibranor
NKTR-214
DS-8201
GSK2857916
ozanimod
SGT-001
valoctocogene roxaparvovec
voxelotor
3 Biotechs With Potential Blockbusters Near the Finish Line
Motley Fool
Tue, 12/18/18 - 12:48 pm
Vertex Pharmaceuticals
VX-659 + tezacaftor + ivacaftor
Celgene
JCAR017
Novo Nordisk
semaglutide
Novo Nordisk’s Semaglutide Hits Mark in Type 2 Diabetes Trial
BioSpace
Mon, 08/20/18 - 10:42 pm
Novo Nordisk
clinical trials
semaglutide
type 2 diabetes
Novo Nordisk trumpets more Januvia-topping data for oral semaglutide
Fierce Pharma
Fri, 06/29/18 - 10:20 am
Novo Nordisk
semaglutide
Merck
Januvia
HbA1C
Novo Nordisk's oral semaglutide impresses analysts against Victoza, Januvia
Fierce Pharma
Thu, 06/21/18 - 10:58 pm
Novo Nordisk
diabetes
semaglutide
Victoza
Merck
Januvia
Novo Nordisk's oral diabetes drug beats Jardiance in study
Yahoo/Reuters
Tue, 05/29/18 - 11:07 pm
diabetes
Novo Nordisk
semaglutide
Jardiance
Eli Lilly
Novo Nordisk's semaglutide spurs major weight loss in phase 2 obesity study
Fierce Pharma
Mon, 03/19/18 - 11:40 pm
Novo Nordisk
obesity
semaglutide
In a turf war with Eli Lilly, Novo Nordisk steps off with positive PhIII for its challenging oral GLP-1 drug
Endpoints
Thu, 02/22/18 - 09:12 am
Novo Nordisk
Eli Lilly
diabetes
clinical trials
semaglutide
Trulicity
Bring on Novo Nordisk’s semaglutide, Eli Lilly says. We’re ready
Fierce Pharma
Mon, 02/12/18 - 11:00 am
Novo Nordisk
semaglutide
Eli Lilly
Ozempic
Trulicity
5 Biggest New Drugs of 2018
Motley Fool
Sun, 01/7/18 - 12:35 pm
Gilead Sciences
Bictegravir/F/TAF
Novo Nordisk
semaglutide
Ozempic
Incyte
epacadostat
AbbVie
Rova-T
Celgene
ozanimod
Pages
« first
‹ previous
1
2
3
4
next ›
last »